Clinical Trials
2 trialsNCT06103279 2023-10-26
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Ain Shams University
Phase 2/3 Unknown
NCT05200793 2022-01-21
Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
Alexandria University
Phase 4 Unknown